NCT00151671 - Effect of a Perioperative Oral Nutritional Supplementation on Patients Undergoing Hepatic Surgery for Liver Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2003

Primary Completion Date

April 30, 2008

Study Completion Date

September 30, 2008

Conditions

Liver CancerHepatocellular CarcinomaCirrhosisLiver Fibrosis

Interventions

DRUG

Oral Impact®

Oral nutritional supplement containing L-arginin, ω3 polyunsaturated fatty acids, and nucleotides. Given three times a day for the 7 last preoperative and the first 3 postoperative days.

DRUG

Placebo

Oral solution of placebo. Given three times a day for the 7 last preoperative and the first 3 postoperative days.

Trial Locations (1)

35033

Service de Réanimation Chirurgicale - Hôpital Pontchaillou, Rennes